Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 10 | 2023 | 83 | 3.030 |
Why?
|
| Lymphatic Abnormalities | 5 | 2022 | 29 | 2.660 |
Why?
|
| Hemangioma | 7 | 2023 | 154 | 2.300 |
Why?
|
| Hemangioendothelioma | 4 | 2020 | 35 | 1.530 |
Why?
|
| Kasabach-Merritt Syndrome | 3 | 2020 | 16 | 1.380 |
Why?
|
| Sirolimus | 8 | 2023 | 814 | 1.330 |
Why?
|
| Sarcoma, Kaposi | 3 | 2020 | 187 | 1.200 |
Why?
|
| Lymphangioma | 2 | 2021 | 36 | 0.980 |
Why?
|
| Chylothorax | 2 | 2021 | 36 | 0.970 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2023 | 54 | 0.880 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2021 | 726 | 0.850 |
Why?
|
| Osteolysis, Essential | 1 | 2021 | 6 | 0.800 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2021 | 25 | 0.790 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 234 | 0.750 |
Why?
|
| Pleural Effusion | 1 | 2021 | 201 | 0.720 |
Why?
|
| Vascular Neoplasms | 1 | 2020 | 114 | 0.700 |
Why?
|
| Expert Testimony | 1 | 2019 | 90 | 0.670 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2023 | 7 | 0.450 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 2403 | 0.430 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 262 | 0.430 |
Why?
|
| Arteriovenous Malformations | 2 | 2019 | 70 | 0.420 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2011 | 37 | 0.390 |
Why?
|
| Upper Extremity | 1 | 2011 | 87 | 0.370 |
Why?
|
| Lymphatic Vessels | 2 | 2021 | 143 | 0.350 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 123 | 0.340 |
Why?
|
| Blood Vessels | 1 | 2010 | 217 | 0.340 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 345 | 0.310 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 301 | 0.310 |
Why?
|
| Child | 18 | 2023 | 29154 | 0.310 |
Why?
|
| Congenital Abnormalities | 1 | 2010 | 260 | 0.300 |
Why?
|
| Infant | 12 | 2023 | 13310 | 0.300 |
Why?
|
| Ascites | 2 | 2018 | 198 | 0.300 |
Why?
|
| Drainage | 2 | 2021 | 416 | 0.300 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 4557 | 0.300 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8223 | 0.280 |
Why?
|
| Neutropenia | 2 | 2020 | 968 | 0.260 |
Why?
|
| Thrombocytopenia | 2 | 2021 | 846 | 0.250 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 4654 | 0.250 |
Why?
|
| Lymphatic System | 2 | 2021 | 64 | 0.240 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2022 | 41 | 0.220 |
Why?
|
| Humans | 35 | 2023 | 261506 | 0.220 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 82 | 0.200 |
Why?
|
| Otolaryngology | 1 | 2023 | 129 | 0.200 |
Why?
|
| Octreotide | 1 | 2021 | 118 | 0.200 |
Why?
|
| Angiomatosis | 1 | 2021 | 26 | 0.200 |
Why?
|
| Rhabdomyoma | 1 | 2021 | 23 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 1547 | 0.190 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 128 | 0.180 |
Why?
|
| Hemangioma, Capillary | 1 | 2020 | 35 | 0.180 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2020 | 53 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2022 | 246 | 0.180 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 58 | 0.180 |
Why?
|
| Accelerated Idioventricular Rhythm | 1 | 2019 | 1 | 0.180 |
Why?
|
| Ethiodized Oil | 1 | 2019 | 15 | 0.170 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2019 | 19 | 0.170 |
Why?
|
| Muscle Weakness | 1 | 2020 | 116 | 0.170 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 590 | 0.160 |
Why?
|
| Peritoneovenous Shunt | 1 | 2018 | 6 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 214 | 0.160 |
Why?
|
| Lymphedema | 1 | 2021 | 239 | 0.160 |
Why?
|
| Chylous Ascites | 1 | 2017 | 25 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 830 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 231 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2022 | 16273 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2023 | 37905 | 0.140 |
Why?
|
| Critical Illness | 1 | 2021 | 714 | 0.140 |
Why?
|
| Thrombocytosis | 1 | 2017 | 121 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 621 | 0.140 |
Why?
|
| Consensus | 1 | 2019 | 978 | 0.130 |
Why?
|
| Iron Chelating Agents | 1 | 2014 | 33 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 600 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 986 | 0.120 |
Why?
|
| Iron Overload | 1 | 2014 | 35 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 1375 | 0.120 |
Why?
|
| Anemia | 1 | 2020 | 689 | 0.120 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 502 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 551 | 0.120 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 102 | 0.120 |
Why?
|
| Male | 15 | 2022 | 123000 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2019 | 2819 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2020 | 925 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 1162 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 2146 | 0.100 |
Why?
|
| Female | 12 | 2023 | 141928 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 550 | 0.100 |
Why?
|
| Registries | 1 | 2018 | 2170 | 0.090 |
Why?
|
| Mass Screening | 1 | 2018 | 1509 | 0.090 |
Why?
|
| Pregnancy | 1 | 2023 | 7573 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 2488 | 0.090 |
Why?
|
| Medical Oncology | 1 | 2018 | 1423 | 0.090 |
Why?
|
| Radiology, Interventional | 2 | 2022 | 138 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2010 | 94 | 0.090 |
Why?
|
| Pediatrics | 1 | 2018 | 1141 | 0.090 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 1866 | 0.080 |
Why?
|
| Prognosis | 4 | 2020 | 21713 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 203 | 0.080 |
Why?
|
| Adolescent | 7 | 2022 | 31252 | 0.080 |
Why?
|
| Young Adult | 3 | 2023 | 21445 | 0.080 |
Why?
|
| Gap Junctions | 1 | 2007 | 43 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2011 | 1544 | 0.070 |
Why?
|
| Connexins | 1 | 2007 | 78 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2022 | 5542 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2007 | 124 | 0.070 |
Why?
|
| Mutation | 3 | 2022 | 15179 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1467 | 0.070 |
Why?
|
| Leukemia | 1 | 2014 | 1635 | 0.070 |
Why?
|
| United States | 2 | 2023 | 15433 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2527 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 7702 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 6295 | 0.060 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2022 | 10 | 0.060 |
Why?
|
| Activin Receptors, Type II | 1 | 2022 | 38 | 0.060 |
Why?
|
| Propranolol | 1 | 2023 | 156 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2022 | 48 | 0.050 |
Why?
|
| Endothelium, Lymphatic | 1 | 2021 | 14 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2023 | 32848 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2023 | 323 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 435 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 1439 | 0.050 |
Why?
|
| Oseltamivir | 1 | 2020 | 33 | 0.050 |
Why?
|
| Adult | 3 | 2022 | 77950 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2020 | 90 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4078 | 0.040 |
Why?
|
| Algorithms | 1 | 2010 | 3890 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 197 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 773 | 0.040 |
Why?
|
| Vomiting | 1 | 2020 | 354 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 854 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2010 | 7226 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2018 | 232 | 0.040 |
Why?
|
| Fever | 1 | 2020 | 497 | 0.040 |
Why?
|
| Peritoneum | 1 | 2017 | 150 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2017 | 112 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 2195 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2019 | 560 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 295 | 0.030 |
Why?
|
| Chelation Therapy | 1 | 2014 | 5 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 429 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 482 | 0.030 |
Why?
|
| Fatigue | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 4314 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 1230 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 403 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 14889 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2010 | 11965 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 5377 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 4109 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 1472 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 5687 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 2086 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 4744 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 4532 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1112 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 59536 | 0.020 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2007 | 9 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 24 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4320 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 5539 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 734 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 2084 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 17523 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 14551 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 34495 | 0.000 |
Why?
|